Has Jesse Jangula received payments from drug or device companies?

Yes. Drug and device makers reported $1,325 in general payments to Jesse Jangula across 43 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jesse Jangula did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jesse Jangula come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jesse Jangula

Optometrist · Post Falls, IDNPI 1942534235

Payments from drug & device makers

$1,325in general payments, 2019–2025

Across 43 payments — averaging $30.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biotissue Holdings Inc.$251
Sun Pharmaceutical Industries Inc.$221
Johnson & Johnson Vision Care, Inc.$198
ABB Con-cise Optical Group LLC$145
Alcon$134
Bausch & Lomb Americas Inc.$88
plus $288 from 11 others

What the payments were for

Food & beverage$1,22492%
Gifts$191%
Entertainment$816%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biotissue Holdings Inc.	6	$251
Sun Pharmaceutical Industries Inc.	5	$221
Johnson & Johnson Vision Care, Inc.	9	$198
ABB Con-cise Optical Group LLC	3	$145
Alcon	5	$134
Bausch & Lomb Americas Inc.	4	$88
Optos, Inc.	1	$81
AbbVie	1	$28
Rxsight Inc	1	$26
Thea Pharma Inc.	1	$25
Harrow Eye, LLC	1	$24
Mallinckrodt Hospital Products Inc.	1	$22
Carl Zeiss Meditec AG	1	$19
Oyster Point Pharma, Inc.	1	$18
Tarsus Pharmaceuticals, Inc.	1	$18
Novartis	1	$15
Actelion Pharmaceuticals US, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CEQUA$125

How this compares

$1,325 in reported general payments places this provider in the 70th percentile of 304 optometrist providers in Idaho.

See all optometrist providers in Idaho →

Medicare billing

Part B allowed, 2024

$40,489

Medicare patients

244

Services billed

482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cyclosporine	18	$5,088
Timolol Maleate	32	$1,577
Latanoprost	96	$1,029
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	28	$366

Paid to pharmacies, not to this prescriber.